Compare Humana Inc (HUM) vs Nu Holdings Ltd (NU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Nu Holdings Ltd — how do they compare? Humana Inc trades at $400 (market cap $47.81B), while Nu Holdings Ltd trades at $14.03 (market cap $67.58B). The key difference: Nu Holdings Ltd is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals.
| HUM | NU | |
|---|---|---|
Market Cap | $47.81B | $67.58B |
Sector | Health | Financials |
52-Week High | $409.42 | $18.76 |
52-Week Low | $163.67 | $11.60 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
NU stock trades at $14.125, up 3.94% today, with a bearish technical signal but strong fundamentals including 26.72% net income margin and 30.04% ROE. Recent earnings show mixed results with two misses, but revenue growth accelerated from $3.0B in 2022 to $10.63B in 2025. The company secured banking approval in Mexico, expanding its Latin American footprint to 15 million customers as of July 2026 (Bloomberg, 2026-07-15).
Outlook remains positive with a $14.98 consensus price target (54.55% buy ratings), though risks include high P/E of 20.96 and debt-to-asset ratio volatility. Growth catalysts from Mexico expansion and digital banking dominance support long-term potential, but near-term headwinds from earnings misses and competitive pressures warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
